Health Services · Medical/Nursing Services · NSE: LOTUSEYE · data 2026-10-09
Lotus Eye Hospital And Institute Ltd
Health check: Weak (2.7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹113.93
Market cap
₹237 cr
P/E
1,586.8
P/B
—
ROE
0.1%
ROCE
-0.3%
Debt / equity
0.26
Dividend yield
0.00%
1-year return
-5.1%
52-week high
₹147
52-week low
₹97.59
Operating margin
0.5%
Growth
| Revenue (last 12 months) | ₹57 cr |
| Net profit (last 12 months) | ₹0 cr |
| Sales growth, 3 years (yearly) | 4.5% |
| Profit growth, 3 years (yearly) | -73.0% |
Similar companies
Gaudium IVF & Women Health Ltd. (GAUDIUMIVF) · CHANDAN HEALTHCARE LIMITED (CHANDAN) · Rays of Belief Limited (MOMSBELIEF) · Pramodini Medicare Limited (PRAMODINI) · Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open LOTUSEYE in NSE Scanner →